Revised FIGO staging system for gestational trophoblastic tumors: Recommendations regarding therapy

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 43, Issue 1, 1998, Pages 37-43

  Goldstein, Donald P ^a,b   Zanten Przybysz, Iwona V ^a   Bernstein, Marilyn R ^a   Berkowitz, Ross S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b New England Trophoblastic Disease Center   (United States)

Author keywords

FIGO; Trophoblastic neoplasms; Tumor staging

Indexed keywords

CHORIONIC GONADOTROPIN; DACTINOMYCIN; FOLINIC ACID; METHOTREXATE;

CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER STAGING; CONFERENCE PAPER; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; TREATMENT OUTCOME; TROPHOBLASTIC TUMOR;

ANTIMETABOLITES, ANTINEOPLASTIC; FEMALE; HUMANS; METHOTREXATE; NEOPLASM STAGING; PREGNANCY; PROGNOSIS; TROPHOBLASTIC NEOPLASMS; UTERINE NEOPLASMS; WORLD HEALTH ORGANIZATION;

EID: 0031885133     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Ross GT, Goldstein DP, Hertz R, et al: Sequential use of methotrexate and actinomycin-D in the treatment of metastatic choriocarcinoma and related trophoblastic diseases in women. Am J Obstet Gynecol 1965;93:223-229
2. Hammond DB, Borchert LG, Tyrey L, et al: Treatment of metastatic trophoblastic disease: Good and poor prognosis. Am J Obstet Gynecol 1973;115:451-457
3. Bagshawe KD: Risk and prognostic factors in trophoblastic neoplasia. Cancer 1976;38:1373-1385
4. World Health Organization Scientific Group: Gestational trophoblastic diseases. Technical report series no. 692. Geneva, Switzerland, WHO, 1983
5. Sung HZ, Wu PC, Tong MY, et al: A staging system of gestational trophoblastic neoplasms based on the development of the disease. Chin Med J 1984;97:557-566
6. FIGO Oncology Committee Report. Int J Obstet Gynecol 1992;39:149-150
7. Ngan HYS, Lopes ADB, Lauder IJ, et al: An evaluation of the prognostic factors in metastatic gestational trophoblastic disease. Int J Gynecol Cancer 1994;4:36-41
8. Lurain JR, Casanova LA, Miller DS, et al: Prognostic factors in gestational trophoblastic tumors: A proposed new scoring system based on multivariate analysis. Am J Obstet Gynecol 1991;164:611-616
9. Soper JT, Clarke-Pearson DL, Hammond CB: Metastatic gestational trophoblastic tumors: Prognostic factors in previously untreated patients. Obstet Gynecol 1988;71:338-343
10. Azab MB, Pejovic MH, Theodore C, et al: Prognostic factors in gestational trophoblastic tumors. A multivariate analysis. Cancer 1988;62:585-592
11. Soper JT, Evans AC, Conaway MR, et al: Evaluation of prognostic factors and staging in gestational trophoblastic tumors. Obstet Gynecol 1994;84:969-973
12. DuBeshter B, Berkowitz RS, Goldstein DP, et al: Metastatic gestational trophoblastic disease: Experience at the New England Trophoblastic Disease Center, 1965-1985. Obstet Gynecol 1987;69:390-395
13. Ayhan A, Yapar EG, Deren O, et al: Remission rates and significance of prognostic factors in gestational trophoblastic tumors. J Reprod Med 1992;37:461-465
14. Mortakis AE, Braga CA: "Poor prognosis" metastatic gestational trophoblastic disease: The prognostic significance of the scoring system in predicting chemotherapy failures. Obstet Gynecol 1990;76:272-277
15. Dubuc-Lissior JD, Sweizig S, Schlaerth JB, et al: Metastatic gestational trophoblastic disease: A comparison of prognostic classification systems. Gynecol Oncol 1992;45: 40-45
16. Mutch DG, Soper JT, Baker ME, et al: Role of computed axial tomography of the chest in staging patients with non-metastatic gestational trophoblastic disease. Obstet Gynecol 1986;68:348-352
17. Dessaur R, Rustin G, Dent J, et al: Surgery and chemotherapy in the management of placental site tumour. Gynecol Oncol 1990;339:56-59
18. Berkowitz RS, Goldstein DP, Bernstein MR. Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 1986;23: 111-118
19. Bagshawe KD: Treatment of trophoblastic tumors. Recent Results Cancer Res 1977;62:192-199
20. Holmesley HD, Blessing JA, Rettenmaier M, et al: Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Obstet Gynecol 1988;72:413-418
21. Petrilli ES, Twiggs LB, Blessing JA, et al: Single-dose actinomycin-treatment for nonmetastatic gestational trophoblastic disease: A prospective phase II trial of the gynecologic oncology group. Cancer 1987;60:2173-2176
22. Rustin GJS, Newlands ES, Lutz JM, et al: Combination but not single-agent methotrexate chemotherapy for gestational trophobalstic tumors increases the incidence of second tumors. J Clin Oncol 1996;14:2769-2773
23. Bower M, Newlands ES, Holden L, et al: EMA/CO for high risk gestational trophoblastic tumors: Results from a cohort of 272 patients. J Clin Oncol 1997;15:2636-2641
24. Rustin GJS, Newlands ES, Begent RHJ, et al: Weekly alternating etoposide, methotrexate, actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. J Clin Oncol 1989;7: 900-903